References
- Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Marc GP, Moreira ED, Zerbini C, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020 Dec 31;383(27):2603–2. Epub 2020 Dec 10. doi:10.1056/NEJMoa2034577.
- AIFA. Rapporto sulla Sorveglianza dei vaccini COVID-19. https://www.aifa.gov.it/documents/20142/1315190/Rapporto_sorveglianza_vaccini_COVID-19_1.pdf/9d9b4c1f-ea05-c87e-426e-29d14dee1a6b
- CDC COVID-19 Response Team and Food and Drug Administration. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine — United States, December 14–23, 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):46–51. doi:10.15585/mmwr.mm7002e1.
- GOV.UK. Coronavirus vaccine - weekly summary of Yellow Card reporting. https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting#yellow-card-reports
- Krammer F, Srivastava K, Team P, et al. Robust spike antibody responses and increased reactogenicity in seropositive individuals after a 1 single dose of SARS-CoV-2 mRNA vaccine 2 3. medRxiv. 2021. medRxiv preprint. doi:10.1101/2021.01.29.21250653;.
- Oliver SE, Gargano JW, Marin M, Wallace M, Curran KG, Chamberland M, McClung N, Campos-Outcalt D, Morgan R, Mbaeyi S, et al. The advisory committee on immunization practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine — United States, December 2020. MMWR Morb Mortal Wkly Rep. 2020 Dec 18;69(50):1922–24. doi:10.15585/mmwr.mm6950e2.
- Saadat S, Rikhtegaran-Tehrani Z, Logue J, et al. Single dose vaccination in healthcare workers previously infected with SARS-CoV-2. medRxiv. 2021. doi:10.1101/2021.01.30.21250843.
- Adler K. Covid: why is EU’s vaccine rollout so slow? BBC NEWS. 2021. https://www.bbc.com/news/world-europe-55844268